Ephedrine
Natural health product licensed in Canada
- Other names
- Ephedrine HCl
- Licence holder
- Diversified Nutrition Lifestyle Canada Ltd.
- NPN or DIN-HM
- 80045642
- Status
- Inactive licence
- Licence date
- 22 October 2013
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| L-éphédrine Source : Chlorhydrate de l-éphédrine | 8 mg | Not calculated |
Non-medicinal ingredients
Dioxyde de silicium, Gélatine, Stéarate de magnésium, Cellulose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes et adolescents | minimum: 12 years | 1 Capsule | minimum: 1 day ; maximum: 4 days |
Uses authorised in Canada
Used as a decongestant/ to relieve nasal congestion. Used as a decongestant/ to relieve nasal congestion (due to flu). Used as a decongestant/ to relieve nasal congestion (due to hay fever/allergic rhinitis /allergies). Used as a decongestant/ to relieve nasal congestion (due to sinusitis). Used as a decongestant/ to relieve nasal congestion (due to the common cold).
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
Shortness of breath; and/or disturbance of urination have been known to occur; in which case; discontinue use. Severe headache has been known to occur; in which case; discontinue use. Restlessness has been known to occur; in which case; discontinue use. Rapid heartbeat has been known to occur; in which case; discontinue use. Nausea and/or loss of appetite have been known to occur; in which case; discontinue use. Irritability; dizziness and/or tremor have been known to occur; in which case; discontinue use. Insomnia has been known to occur; in which case; discontinue use.
- Précautions et mises en garde
Keep out of reach of children. Consult a health care practitioner prior to use if you have thyroid problems. Consult a health care practitioner prior to use if you have seizure disorders. Consult a health care practitioner prior to use if you have pre-existing psychiatric conditions. Consult a health care practitioner prior to use if you have glaucoma. Consult a health care practitioner prior to use if you have difficulty in urination due to prostate enlargement. Consult a health care practitioner prior to use if you have diabetes. Consult a health care practitioner prior to use if you have cardiovascular disease. Consult a healthcare practitioner prior to use if you are taking other products which contain pseudoephedrine. Consult a healthcare practitioner prior to use if you are taking other products which contain phenylpropanolamine. Consult a healthcare practitioner prior to use if you are taking other products which contain ephedrine. Consult a healthcare practitioner prior to use if you are taking other products which contain caffeine. Consult a health care practitioner prior to use if you are taking medication and/or natural health products for weight control. Consult a health care practitioner prior to use if you are taking medication and/or natural health products for cough/cold. Consult a health care practitioner prior to use if you are taking medication and/or natural health products for asthma. Consult a health care practitioner prior to use if you are taking medication and/or natural health products for allergy symptoms. Consult a health care practitioner prior to use if you are pregnant or breastfeeding. Consult a health care practitioner if symptoms worsen. Consult a health care practitioner if symptoms persist.
- Contre-indications
Do not use if you are taking; or have taken in the past two weeks monoamine oxidase (MAO) inhibitors.
Source
Official Health Canada record, licence 80045642
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.